InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,528.93
(
-2.12%
)
US TECH 100
18,424.00
(
-3.29%
)
Dow Jones
40,936.93
(
-1.51%
)
Brent Oil
73.29
(
-0.46%
)
Bitcoin
56,146.17
(
-2.22%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bradrad

Send PM Follow Ignore
Followers 11
Posts 229
Boards Moderated 0
Alias Born 12/10/2013

bradrad

Re: ahab333 post# 41410

Wednesday, 11/08/2017 11:21:20 PM

Wednesday, November 08, 2017 11:21:20 PM

Post# of 48316
With all studies being completed with Keytruda, would ONCS have to start over with trials for other indications?

I agree licensing could be lucrative but what’s the timeline for usage with other indications?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM

UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM

Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!